CTOs on the Move

Harris, Wiltshire & Grannis

www.hwglaw.com

 
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.hwglaw.com
  • 1919, M Street Northwest
    Washington, DC USA 20036
  • Phone: 202.730.1300

Executives

Name Title Contact Details

Similar Companies

SafeMoon

SafeMoon is a human-focused and privately-held technology company headquartered in Utah with a secondary presence in the U.K. SafeMoon introduced its unique protocol and vision in early 2021, quickly rising to support an audience of multiple million participants (the #SAFEMOONARMY) by January 2022). SafeMoon`s longer-term goal is the advancement of its Defi products and services into an ecosystem that makes the blockchain`s power available to a much broader community, and to include the power of this vast community to support and advance new sustainable technologies in a model of Venture Philanthropy, to create and propel innovations for good while also producing a profit and a sustainable model for growth

TrustWrx

TrustWrx is a low cost, hands-free enterprise-class security service that protects the networks, computers, and smart devices in connected homes, small businesses, and smart cities.

Homebridge Financial Services

Whether youre buying a new home or refinancing, Homebridge is your trusted home mortgage lender to help you find the right loan - FHA, First Time Home Buyer, Conventional, Renovation, Reverse and more! Explore our many loan product options today!

Logicworks

Logicworks is a cloud computing and managed services company headquartered in New York City with offices in Seattle, Washington DC, and London.

Perthera

Perthera, Inc. is a service company that helps guide patients and their physicians to the best cancer treatment options available by bridging the gap between molecular testing and patient therapy. We provide a more complete view of the molecular pathways driving advanced stage cancer than any other company. By combining genomics, proteomics and clinical history, Perthera delivers a comprehensive molecular analysis of a patient`s tumor and identifies the best available FDA approved therapies and clinical trials for each individual patient.